Evidence map›Paper›PMID 31775777›Full record

ArticleRespiratory research2019

Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study.

Libing Yang, Ghady Haidar, Haris Zia, Rachel Nettles, Shulin Qin, Xiaohong Wang, Faraaz Shah, Sarah F Rapport, Themoula Charalampous, Barbara Methé and 5 more

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06538441 (Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia), which is not on this map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06538441 active not recruitingnot on this mapstarted 2024, after this paper: background citation

Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia: a Longitudinal Observational Study

TypeobservationalSponsorShanghai General Hospital, ChinaRan2024 to 2025Enrolled600ConditionsSevere Pneumonia
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Microbiome Profiling Reveals Prognostic Heterogeneity inmedRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in cellular and infection microbiology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Libing YangCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Ghady HaidarDivision of Infectious Diseases, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Haris ZiaInternal Medicine Residency Program, University of Pittsburgh Medical Center McKeesport, McKeesport, PA, USA.
Rachel NettlesCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Shulin QinCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Xiaohong WangCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Faraaz ShahDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, UPMC Montefiore Hospital, NW628, 3459 Fifth Avenue, Pittsburgh, PA, 15213, USA.
Sarah F RapportDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, UPMC Montefiore Hospital, NW628, 3459 Fifth Avenue, Pittsburgh, PA, 15213, USA.
Themoula CharalampousBob Champion Research and Educational Building, University of East Anglia, Norwich Research Park, Norwich, UK.
Barbara MethéCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Adam FitchCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Alison MorrisCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Bryan J McVerryCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA.
Justin O'GradyBob Champion Research and Educational Building, University of East Anglia, Norwich Research Park, Norwich, UK.
Georgios D KitsiosCenter for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA, USA. kitsiosg@upmc.edu.ORCID http://orcid.org/0000-0002-1018-948X

Funding

Regulation of Cardiolin Byosynthesis in Epithelial InjuryP01HL114453 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2014 to 2023
$21.3M
Sepsis-Associated Immune Suppression and F-box ProteinsR01HL097376 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2009 to 2025
$5.1M
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIVU01HL098962 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GHEDIN, ELODIE, MORRIS, ALISON · 2009 to 2013
$3.8M
Microbiome-based diagnosis of pneumonia in the acute respiratory distress syndromeK23HL139987 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KITSIOS, GEORGIOS · 2018 to 2022
$806k
Metabolic Effects of Early Nutritional Support in Sepsis: A Translational InvestigationK23GM122069 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHAH, FARAAZ ALI · 2016 to 2020
$764k
Mentoring and Patient-Oriented Research in HIV Obstructive Lung DiseaseK24HL123342 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2014 to 2018
$571k
Biotechnology and Biological Sciences Research Council BB/R012504/1Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10348Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10349Department of Health RP-PG-0514-20018Medical Research Council MR/N013956/1NHLBI NIH HHS K23 HL139987NHLBI NIH HHS K24 HL123342NHLBI NIH HHS P01 HL114453NHLBI NIH HHS R01 HL097376NHLBI NIH HHS U01 HL098962NIGMS NIH HHS K23 GM122069
6 · The paper itself

Abstract

backgroundMetagenomic sequencing of respiratory microbial communities for pathogen identification in pneumonia may help overcome the limitations of culture-based methods. We examined the feasibility and clinical validity of rapid-turnaround metagenomics with Nanopore™ sequencing of clinical respiratory specimens.

methodsWe conducted a case-control study of mechanically-ventilated patients with pneumonia (nine culture-positive and five culture-negative) and without pneumonia (eight controls). We collected endotracheal aspirates and applied a microbial DNA enrichment method prior to metagenomic sequencing with the Oxford Nanopore MinION device. For reference, we compared Nanopore results against clinical microbiologic cultures and bacterial 16S rRNA gene sequencing.

resultsHuman DNA depletion enabled in depth sequencing of microbial communities. In culture-positive cases, Nanopore revealed communities with high abundance of the bacterial or fungal species isolated by cultures. In four cases with resistant clinical isolates, Nanopore detected antibiotic resistance genes corresponding to the phenotypic resistance in antibiograms. In culture-negative pneumonia, Nanopore revealed probable bacterial pathogens in 1/5 cases and Candida colonization in 3/5 cases. In controls, Nanopore showed high abundance of oral bacteria in 5/8 subjects, and identified colonizing respiratory pathogens in other subjects. Nanopore and 16S sequencing showed excellent concordance for the most abundant bacterial taxa.

conclusionsWe demonstrated technical feasibility and proof-of-concept clinical validity of Nanopore metagenomics for severe pneumonia diagnosis, with striking concordance with positive microbiologic cultures, and clinically actionable information obtained from sequencing in culture-negative samples. Prospective studies with real-time metagenomics are warranted to examine the impact on antimicrobial decision-making and clinical outcomes.

Indexed as

NanoporesAnti-Bacterial AgentsCase-Control StudiesDNA, BacterialFeasibility StudiesFemaleHigh-Throughput Nucleotide SequencingHumansMaleMetagenomicsMicrobiotaPneumoniaReference ValuesRespiration, ArtificialRespiratory InsufficiencyRisk FactorsAnti-Bacterial AgentsDNA, BacterialVirulence FactorsMechanical ventilationMetagenomics sequencingNanoporePathogen detectionPneumonia

Identifiers

PMID31775777
PMCPMC6882222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.